Dr. Dulabh Monga, MD
Claim this profileAllegheny General Hospital
Area of expertise
Pancreatic Cancer
Dulabh Monga, MD has run 5 trials for Pancreatic Cancer. Some of their research focus areas include:
Liver Cancer
Dulabh Monga, MD has run 2 trials for Liver Cancer. Some of their research focus areas include:
Affiliated Hospitals
Allegheny General Hospital
Forbes Hospital
Clinical Trials Dulabh Monga, MD is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting
1 award
Phase 2
3 criteria
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting
1 award
Phase 2 & 3
More about Dulabh Monga, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Dulabh Monga, MD has experience with
- Lenvatinib
- Irinotecan
- Nivolumab
- Ipilimumab
- Sorafenib
- Atezolizumab
Breakdown of trials Dulabh Monga, MD has run
Pancreatic Cancer
Liver Cancer
Colon Cancer
Pancreatic Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dulabh Monga, MD specialize in?
Dulabh Monga, MD focuses on Pancreatic Cancer and Liver Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Dulabh Monga, MD currently recruiting for clinical trials?
Yes, Dulabh Monga, MD is currently recruiting for 2 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Dulabh Monga, MD has studied deeply?
Yes, Dulabh Monga, MD has studied treatments such as Lenvatinib, Irinotecan, Nivolumab.
What is the best way to schedule an appointment with Dulabh Monga, MD?
Apply for one of the trials that Dulabh Monga, MD is conducting.
What is the office address of Dulabh Monga, MD?
The office of Dulabh Monga, MD is located at: Allegheny General Hospital, Pittsburgh, Pennsylvania 15212 United States. This is the address for their practice at the Allegheny General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.